Proteomic analyses of serous and endometrioid epithelial ovarian cancers - Cases studies - Molecular insights of a possible histological etiology of serous ovarian cancer-Reference-Cited by-同舟云学术

Proteomic analyses of serous and endometrioid epithelial ovarian cancers - Cases studies - Molecular insights of a possible histological etiology of serous ovarian cancer

Published:2013-06 Issue:5-6 Volume:7 Page:337-354
ISSN:1862-8346
Container-title:PROTEOMICS - Clinical Applications
language:en
Short-container-title:Prot. Clin. Appl.

Author:

Longuespée Rémi¹²,Gagnon Hugo¹²,Boyon Charlotte¹³,Strupat Kurstin⁴,Dauly Claire⁵,Kerdraon Olivier⁶,Ighodaro Adesuwa¹⁷,Desmons Annie¹,Dupuis Jocelyn⁵,Wisztorski Maxence¹,Vinatier Denis¹³,Fournier Isabelle¹,Day Robert²,Salzet Michel¹

Affiliation:

1. Université Nord de France, LSMBFA, MALDI Imaging Team, EA 4550, Université de Lille 1, SIRIC ONCOLILLE, Cité Scientifique; Villeneuve D'Ascq; France

2. Institut de pharmacologie de Sherbrooke et Département de chirurgie/urologie, Faculté de médecine et des sciences de la santé, Université de Sherbrooke; Sherbrooke Québec Canada

3. Hôpital Jeanne de Flandre, service de Chirurgie Gynécologique, CHRU de Lille; France

4. Thermo Fisher Scientific (Bremen) GmbH; Bremen Germany

5. Thermo Fisher Scientific (France), Silic; Courtaboeuf; France

6. Laboratoire d'Anatomie et de Cytologie Pathologiques, CHRU de Lille; Lille France

7. OWNIP fellow, SUNY College at Old Westbury; Old Westbury NY USA

Funder

collaboration between The Fundamental and Applied Biology Mass Spectrometry laboratory

Centre National de la Recherche Scientifique

Publisher

Wiley

Subject

Clinical Biochemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/prca.201200079/fullpdf

Reference74 articles.

1. The cell of origin of ovarian epithelial tumours;Dubeau;Lancet Oncol.,2008

2. Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis;Shih Ie;Am. J. Pathol.,2004

3. Early de novo ovarian carcinoma. A study of fourteen cases;Bell;Cancer,1994

4. Radical fimbriectomy: a reasonable temporary risk-reducing surgery for selected women with a germ line mutation of BRCA 1 or 2 genes? Rationale and preliminary development;Leblanc;Gynecol. Oncol.,2011

5. Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction;Callahan;J. Clin. Oncol.,2007

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mass spectrometry imaging in gynecological cancers: the best is yet to come;Cancer Cell International;2022-12-19

2. Microproteomic sample preparation;PROTEOMICS;2021-03-05

3. MALDI-MSI—A Step Forward in Overcoming the Diagnostic Challenges in Ovarian Tumors;International Journal of Environmental Research and Public Health;2020-10-18

4. Emerging role of clinical mass spectrometry in pathology;Journal of Clinical Pathology;2019-11-05

5. Proteomic Analysis of Low-Grade Serous Ovarian Cancer and Comparing It with Non-cancerous Ovarian;Indian Journal of Gynecologic Oncology;2018-03-28